Discover B2B companies, suppliers, and manufacturers related to this keyword category
APIs & Pharmaceutical Intermediates
We are a pharmaceutical company manufacturing and marketing generic & branded products in Lebanon & regional markets
The future of neuroimaging is here. Qynapse offers groundbreaking peace of mind by providing results you can trust.
Since 1906 our mission is innovating Cure & Care to make patients’ lives better.
Transforming Drug Delivery. Transforming Lives.
As a leading full-service global CRO, we work to create solutions that advance new treatments from discovery to reality.
Caring for People's Health as a Trusted Partner
Developing Next Generation Psychedelic Medicines to Treat Mental Illness
The science driven BioPark at the heart of Europe.
Kyowa Kirin International | Making people smile | www.KyowaKirinInternational.com
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases of the CNS.
BioArctic focuses on developing disease modifying treatments for neurodegenerative diseases.
A clinical stage biotech company opening a new frontier in pharmacology
Developing innovative medicines for the treatment of neuropsychiatric and neurodegenerative diseases
Developing transformative treatments for people with neuropsychiatric disorders
A novel technology platform for the delivery of therapeutics across biological barriers
Improving people's lives impacted by central nervous system disorders through meaningful scientific breakthroughs
Advancing a targeted approach to treat GRIN-related disorders and other pediatric neurodevelopmental disorders.
is part of Sumitomo Pharma America as of July 2023
Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.
Innovative platform to transport and deliver viral and non-viral gene therapies to the central nervous system
Advancing medicine for current & future generations.
Promising Better Lives